iceflower
2022-08-10

$Amgen(AMGN)$

The future is in Biotechnology![Cool] [Love] 


A leader in biotechnology based human therapeutic, with historical expertise in renal disease and cancer supportive care products.


Key ratio

-revenue increasing trend

-net income increase to 4.65 from 4.25

-eps 4.25 to 4.65[Like] 

-total debt to equity ratio 15.09[OMG] 

-fcf reduced to 8417 in march from 10497 in Dec 2020


Technical

-well supported by ema200[DOGE] 

-fluctuating around ema20


Factors to consider

-fundamental is solid but debt is too high for me

-good technical trend

-earning report that can always surprised the market in a good way[Call] 

-current US recession period[Warning] 

So, is it a buy for you?[Bless] [serious] 


@Daily_Discussion@TigerPM@TigerStars@CaptainTiger

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment